BioSig Stock (NASDAQ:BSGM)
Previous Close
$1.60
52W Range
$0.20 - $5.00
50D Avg
$1.27
200D Avg
$0.92
Market Cap
$22.92M
Avg Vol (3M)
$290.32K
Beta
0.35
Div Yield
-
BSGM Company Profile
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BSGM Performance
Peer Comparison
Ticker | Company |
---|---|
BMRA | Biomerica, Inc. |
APYX | Apyx Medical Corporation |
CTSO | Cytosorbents Corporation |
LUNG | Pulmonx Corporation |
TIVC | Tivic Health Systems, Inc. |
CLPT | ClearPoint Neuro, Inc. |
NUWE | Nuwellis, Inc. |
TELA | TELA Bio, Inc. |
NPCE | NeuroPace, Inc. |
SRDX | Surmodics, Inc. |
NMTC | NeuroOne Medical Technologies Corporation |
KIDS | OrthoPediatrics Corp. |
XAIR | Beyond Air, Inc. |
BBLG | Bone Biologics Corporation |
BJDX | Bluejay Diagnostics, Inc. |
HSCS | Heart Test Laboratories, Inc. |
INGN | Inogen, Inc. |
VVOS | Vivos Therapeutics, Inc. |
NAOV | NanoVibronix, Inc. |